Milgamma Na Injekt (Thiamine Hydrochloride, Pyridoxine Hydrochloride)

Thiamine hydrochloride is converted in the body to thiamine pyrophosphate, a co‑factor for enzymes of the pyruvate dehydrogenase complex and the citric‑acid cycle. By facilitating carbohydrate oxidation, it supports energy production in nerve and muscle cells. Adequate thiamine also helps maintain normal cardiac function and prevents accumulation of lactate that can lead to metabolic acidosis.

The dose of Milgamma Na Injekt is determined by the prescribing clinician based on the severity of the vitamin deficiency, patient weight, age, and clinical response. The healthcare professional selects the appropriate volume and frequency of intramuscular injection, which may vary from a single loading dose to repeated administrations over several days or weeks. Patients should follow the prescriber’s instructions precisely.

Safety data for Milgamma Na Injekt in pregnancy and lactation are limited. Thiamine and pyridoxine are essential nutrients, and deficiency can be harmful to both mother and fetus. However, the injectable form should only be used when clearly needed and prescribed by a qualified obstetrician or physician. The benefits must outweigh any potential risks, and the prescriber should monitor the mother closely.

To request Milgamma Na Injekt, visit the product page on gnhindia.com and submit an enquiry specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will ask for trade or institutional credentials. After verification, the sales team provides pricing, availability, shipping details—including cold‑chain handling if required—and assists with import documentation.

Milgamma Na Injekt delivers thiamine and pyridoxine directly into muscle tissue, bypassing gastrointestinal absorption, which can be advantageous in patients with malabsorption, vomiting, or severe deficiency. Oral supplements rely on intestinal uptake and may require higher doses to achieve comparable plasma levels. Injectable therapy provides a faster rise in vitamin concentrations, but oral preparations are more convenient for long‑term maintenance.

Milgamma Na Injekt should be stored at 2 °C to 8 °C (refrigerated). Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. If the product is temporarily removed from refrigeration, it must be returned to the recommended temperature range promptly. Proper storage maintains potency and sterility of the injectable solution.

The medication is supplied as a sterile injectable solution for intramuscular injection. A qualified healthcare professional selects an appropriate muscle—commonly the deltoid or gluteal region—and uses a sterile needle and syringe to deliver the prescribed volume. The injection site should be cleaned with an antiseptic, and the patient should be observed for any immediate adverse reactions.

The most serious risks include severe allergic reactions such as anaphylaxis, which may present with rash, swelling, breathing difficulty, or hypotension. Rare neurological events like seizures have been reported, particularly with high doses of pyridoxine. Prompt recognition and medical intervention are essential; patients should be monitored after administration, and any signs of a serious reaction require immediate emergency care.

Milgamma Na Injekt is contraindicated in individuals with known hypersensitivity to thiamine, pyridoxine, or any component of the formulation. Patients who have experienced prior anaphylactic reactions to vitamin B injections should avoid this product. Additionally, it should be used with caution in patients with severe renal impairment, and the decision to treat should be made by a qualified clinician after evaluating risks and benefits.